[ad_1]
Bursa Securities waives need for Group to submit regularisation plan
PETALING JAYA, Malaysia, June 13, 2022 – (ACN Newswire) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that it is uplifted from being classified as an affected listed corporation effective 13 June 2022.
 |
| Azri Azerai, Executive Director of Malaysian Genomics |
 |
| Sasha Nordin, CEO and Dato’ Alvin Nesakumar, Executive Director of Malaysian Genomics [L-R] |
This followed the decision by Bursa Securities Malaysia Berhad to grant the Group a waiver in submitting a regularisation plan after being classified as an affected listed corporation pursuant to Rule 8.03A of the Listing Requirements. Bursa Securities had made the classification according to Rule 8.03A on 24 December 2019 and Malaysian Genomics had submitted an…
Full story available on Benzinga.com
[ad_2]
Source link
